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To the Editor,
Colorectal cancer (CRC) is a leading cause of 
cancer incidence and mortality among adults under 
50 years of age in the USA and is one of the most 
common cancers in the world. It is the third after lung 
cancer and breast cancer, and has a multifactorial 
pathogenesis. Various factors contribute to the 
development of CRC, such as environmental factors, 
chronic inflammatory bowel disease (Crohn’s disease 
and ulcerative colitis), genetic factors and lifestyle 
(such as diet). Combined factors result in an alteration 
of the intestinal flora (knownb as dysbiosis), and a 
release of inflammatory mediators and heat shock 
proteins (HSP) (1, 2), resulting in the establishment of 
a chronic inflammatory process (3, 4). 
These factors, combined with dysbiosis and 
inflammatory processes (5), contribute to an 
increase of oxidative stress, reactive oxygen and 
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Colorectal cancer (CRC) is one of the most common cancers worldwide. Various factors, including 
oxidative stress, where excessive productions of reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) occur, contribute to its pathogenesis. Numerous studies have investigated the effect of 
antioxidant substances derived from food such as fruits and vegetables; however, data on Lycopene 
are still rare. Studies on HT-29 colorectal cancer cells and on animal models have shown that lycopene 
has effects on cell proliferation and on the progression of the CRC by interacting with various cellular 
signaling pathways. This analysis of the literature focused on the antioxidant effect of lycopene, a 
substance that is found in the tomato.
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intervene with the proliferation of cancer cells and 
with the blocking of their oncogenetic transformation 
(8). This update is focused on Lycopene, one of the 
most important exogenous antioxidants.
Lycopene 
Lycopene is a lipophilic pigment responsible for 
the red color in tomatoes with concentrations ranging 
from 0.9 to 9.27 mg/100g, according to the variety 
and ripeness of the tomato (9, 10). Chemically, it 
is an isomer of beta-carotene, with the chemical 
formula C40H56, and contains a hydrocarbon chain 
without any functional group (8-10). In fact, thanks 
to the number of conjugated double bonds present 
in its chemical structure, lycopene is a powerful 
antioxidant. It is able to counteract the ROS, such as 
singlet oxygen and peroxyl radicals (8, 10, 12).  
Lycopene antioxidant action is expressed at 
different levels by:
- inducing the detoxification processes through 
nitrogen species (ROS/RNS) (3). Oxidative stress 
arises from an imbalance between the oxidizing 
and the antioxidant species. ROS (such as hydrogen 
peroxide, hydroxyl radical, superoxide anion and 
peroxynitrite), cause structural alterations on cell 
membranes (such as lipid peroxidation) and on DNA 
(such as genetic instability, point mutations, deletions, 
insertions and aneuploidy). ROS represents one of 
the key factors involved in the development of CRC 
(3, 6, 7).
Among the genes activated by oxidative stress, 
and implicated in the genesis of colorectal cancer, are 
hypoxia-inducible factor-1A (HIFIA) and inducible 
nitric oxide synthase (NOS2A). Both genes increase 
the production of pro-inflammatory cytokines 
(7).  Therefore, to reduce or inhibit carcinogenesis 
linked to oxidative stress, a strategy known as 
“chemoprevention” needs to be adopted which 
involves the administration of exogenous compounds, 
usually contained in fruits and vegetables, which 
Fig. 1. Antioxidant effects of lycopene. The action of the substance takes place at the enzymatic level on glutathione 
peroxidase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and cytochrome P450 2E1 (CYP2E1), 
and at a nuclear level,  on antioxidant response element (ARE).
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metalloproteinase (MMP)-2 (13).
Another study on metalloproteinases, in 
particular of MMP-7, showed how MMP-7 was 
highly expressed in CRC cells and involved in 
tumor progression, development of angiogenesis 
and metastasis. This study, performed on HT-29 
colorectal cancer cell line, investigated the effect of 
lycopene on the expression levels of leptin, the high 
plasma concentrations of which seem to be related to 
increased tumor progression and linked to increased 
expression of MMP-7. It also demonstrated that 
increasing concentrations of lycopene inhibit the 
expression of MMP-7 through inhibition of leptin-
mediated phosphorylation of molecules belonging 
to the signaling pathway phosphoinositide 3-kinase 
(PIK3)/Akt and MAPK/ERK (14).
In reference to other signaling pathways, many 
authors have supported a correlation between 
administration of lycopene and changes in the 
biosynthetic pathway of cholesterol in the tumor 
cells, with consequent reduction of the activation 
of Ras pathway. Colon cancer cell lines HT-29 and 
HCT-116 with mutated Ras, were cultured with 10 
µm of lycopene for 24 hours. The results showed that 
lycopene reduced the cell growth by reducing the 
expression of HmgCoA-reductase and by increasing 
the translocation of Ras from the plasma membrane 
to the cytosol (14). In this respect, the following four 
studies are of particular interest (16-19).
The first study, carried out on HT-29 colorectal 
cancer cell lines, focused on the importance of the 
signaling pathways of PI3K/Akt. This signaling 
pathway when activated in a continuous mode is 
involved in both tumor cell proliferation and in the 
development of angiogenesis. Lycopene appeared to 
inhibit, in a dose-dependent manner, the PIK3/Akt 
pathway by interfering with the phosphorylation 
processes and, thereby, reducing the activation of 
Akt. Lycopene also inhibited the activity of cyclin 
D1 and interfered with the processes of activation of 
cyclin-dependent kinase inhibitor p27kip (16).
The second study, using again the HT-29 
colorectal cancer cell lines in xenograft mice 
models, showed that lycopene has inhibitory effects 
on the growth and progression of CRC. In particular, 
the study documented that lycopene inhibited the 
the production of enzymes of phase I and II. In 
particular, it is documented that lycopene stimulates 
the activity of enzymes such as glutathione peroxidase 
(GPx), glutathione reductase (GR), and glutathione-
S-transferase (GST) (8, 10). The detoxification 
processes are also induced at the nuclear level, 
through the action of the transcription factor nuclear 
factor E2-related factor 2 (Nrf2), which belongs to 
the antioxidant response element (ARE) family (8);
- exerting an inhibitory effect on cytochrome 
P450 2E1 (CYP2E1) which is responsible for the 
conversion of xenobiotics in carcinogenic substances 
(10) (Fig. 1).
The lycopene also plays a role in anti-inflammatory 
activity, which results in the suppression of promotion 
and progression of carcinogenesis and inhibition of 
cell invasion, angiogenesis and metastasis (7).   This 
inhibitory effect is expressed on: 
- growth factors such as insulin-like growth factor 
1 (IGF-1). Lycopene inhibits the binding to the 
receptor by increasing the production of IGFBP-1 
and IGFBP-2) (8);
- angiogenesis, through the inhibition of matrix 
metalloproteinase (MMP)-2 and the urokinase 
plasminogen activator (uPA), which have a 
central role in the metastatic process (8);
- cell cycle by inducing the arrest in G1/S phase 
and inactivation of the Ras signaling pathway (8);
- apoptosis by reducing the expression of the anti-
apoptotic molecule Bcl-2 and increasing the 
activity of caspase 3 and 8 and the pro-apoptotic 
factors Bax and Bim (8).  
Analysis of literature 
There are numerous studies, mostly carried out in 
vitro, depicting the antitumor activity of lycopene, 
with particular reference to CRC. The first in vitro 
study highlighted the action of lycopene on the growth 
of colorectal cancer cell line HT-29. Lycopene, used 
in combination with gold nanoparticles as a vehicle, 
was able to reduce the expression of pro-caspase 3, 
8 and 9 and Bcl-2 and PARP-1, and to increase the 
expression of molecules such as Bax, thus favoring 
the apoptotic process. In addition, there was a 
drastic reduction of cell migration capacity, linked to 
downregulation of Akt, nuclear factor kappa B, and 
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lycopene, in associaton with Bifidobacterium lactisplus 
and oligofructose/inulin, and the expression of ACF. 
The study showed that lycopene supplementation 
(300 mg/kg body weight) for two weeks in mice 
previously treated with carcinogenic substances (such 
as 1,2-dimethylhydrazine), decreased the formation 
of classical and mucin-negative ACF, increased 
apoptosis, and reduced the rates of PCNA and p53-
positive cells (20).
Another study, using the HT-29 colorectal cancer 
cell line and xenograft mice models, investigated the 
association between lycopene and eicosapentaenoic 
acid (EPA) contained in fish oil. The studies 
demonstrated that the association lycopene/EPA 
reduced tumor growth and progression through 
increased expression of cell cycle inhibitors (such 
as p21Cip1/WAF1 and p27Kip1), suppressed by 
molecules related to cell proliferation (such as MMP-
7, MMP-9, COX-2, PGE2, β-catenin, cyclin D1 
growth of cancer cells in CRC-bearing mice by 
inducing apoptosis, suppressing the expression of 
PCNA, modulating the expression of β-catenin and 
E-cadherin and up-regulating the inhibitory proteins 
p21Cip1/WAF1 (17) (Fig. 2). 
Synergistic effect of lycopene
Additional studies showed the synergistic action 
of lycopene in association with other substances. 
Lycopene studies in combination with other substances 
date back to the early 1990s. Two studies, performed 
in 1996 and 1998, showed how the association 
between lycopene, alpha-carotene, beta-carotene, 
lutein, and curcumin, reduced the expression of early 
lesions in CRC, such as aberrant Crypt foci (ACF) 
in mice treated with N-methylnitrosourea (18) or 
1,2-dimethylhydrazine (19).
A similar study was conducted many years later 
and shows the correlation between the consumption of 
Fig. 2. Anticancer effect of lycopene. From literature studies, lycopene shows pro-apoptotic action by reducing the 
expression of anti-apoptotic molecules such as BCL-2, and increasing the production of proapoptotic molecules such 
as BAX. It also shows antiangiogenic and anti-metastatic action, through interference with the PIK3/Akt pathway and 
metalloproteinase inhibition (MMP-7). Finally, it reduces cell proliferation by inhibiting the activity of cyclin D1 and 
causing cell cycle arrest in the G1 / S phase.
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bowel disease and colorectal cancer,  nutraceutical 
aspects. Euromediterranean biomedical journal 
2016; 11(17):123-29
4. Tomasello G, Tralongo P, Damiani P, et al. 
Dismicrobism in inflammatory bowel disease and 
colorectal cancer: changes in response of colocytes. 
World J Gas-troenterol 2014;  20(48):18121-30. 
5. Scardina GA, Pisano T, Carini F, Valenza V, Messina 
P. Burning mouth syndrome: an evaluation of in 
vivo microcirculation. J Am Dent Assoc 2008; 
139(7):940-46.
6. Tomasello G, Mazzola M, Leone A, et al. Nutrition, 
oxidative stress and intestinal dysbiosis: Influence 
of diet on gut microbiota in inflammatory bowel 
diseases. Biomed Pap Med Fac Univ Palacky 
Olomouc Czech Repub 2016; 160(4):461-66.
7. Slattery ML, Lundgreen A, Welbourn B, Wollf RK, 
Corcoran C. Oxidative balance and colon and rectal 
cancer: interaction of lifestyle factors and genes. 
Mutat Res 2012; 734(1-2):30-40.
8. Trejo-Solís C, Pedraza-Chaverrí J, Torres-Ramos M, 
et al. Multiple molecular and cellular mechanisms of 
action of lycopene in cancer inhibition. Evid Based 
Complement Alternat Med 2013; 2013:705121.
9. Milani A, Basirnejad M, Shahbazi S, Bolhassani 
A. Carotenoids: biochemistry, pharmacology and 
treatment.  Br J Pharmacol 2017; 174(11):1290-324.
10. Bandeira AC, da Silva TP, de Araujo GR, et . Lycopene 
inhibits reactive oxygen species production in SK-
Hep-1 cells and attenuates acetaminophen-induced 
liver injury in C57BL/6 mice. Chem Biol Interact 
2016; 263:7-17.
11. Sahin K, Orhan C, Tuzcu M, Sahin N, Hayirli 
A, Bilgili S, Kucuk O. Lycopene activates 
antioxidant enzymes and nuclear transcription 
factor systems in heat-stressed broilers. Poult Sci 
2016; 95(5):1088-95.
12. Boehm F, Edge R, Truscott TG, Witt C. A dramatic 
effect of oxygen on protection of human cells 
against γ-radiation by lycopene. Febs Lett 2016; 
590(8):1086-93.
13. Huang RF, Wei YJ, Inbaraj BS, Chen BH. Inhibition 
of colon cancer cell growth by nanoemulsion carrying 
gold nanoparticles and lycopene. Int J Nanomedicine 
2015; 10:2823-46.
14. Lin MC, Wang FY, Kuo YH, Tang FY. Cancer 
and c-Myc) (21), suppressed by PI-3K/Akt/ mTOR 
pathways, and induction of the expression of Bax 
proteins and Fas ligand proteins (22).
Finally, some studies have shown that the 
association with other antioxidants, such as α-carotene, 
β-carotene, lutein, and Vitamin E, is correlated with 
lycopene. It has been seen that this entire mixture of 
antioxidants inhibits liposome oxidation to a greater 
extent than the intake of individual antioxidants (23).
CONCLUSIONS
Most studies on the antioxidant and antitumoral 
activity of lycopene were performed on animal 
models or CRC cell lines, therefore, to date, the data 
from these studies cannot be translated to humans. 
Targeted studies on lycopene, taken as a dietary 
supplement, such as a primary or a secondary 
prevention measure of CRC in human subjects are 
required. It is also necessary that subsequent studies 
need to focus on the amount or dose of lycopene 
that actually works as an active ingredient, once 
taken orally, so as to create food supplements, a 
nutraceutical that can provide an adequate amount 
of active ingredient to give the desired preventive 
effect. It is also our view to assume a working 
hypothesis concerning the correlation between the 
intake of lycopene and the state of eubiosis of human 
microbiota. In particular, it would be useful to know 
the influence of lycopene on a dysbiotic intestinal 
mucosa, and its possible ability to restore eubiosis 
of intestinal microbiota, thus preventing or blocking 
the chain of events that lead to ACF formation and, 
consequently, CRC.
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